FDA panel OKs two breast cancer drugs

Article Abstract:

The Food and Drug Administration (FDA) has approved breast cancer drugs, Tamoxifen and Herceptin. Tamoxifen is seen to minimize the risk of breast cancer among women as a study on 13,388 high-risk women indicated that after 4 and one half years of therapy, those taking Tamoxifen were 45% less likely to obtain breast cancer than those on a placebo. The second drug, Herceptin, is genetically engineered to block the HER2 protein, which is found in excessive amounts in around one third of breast cancers.

Comment:

The Food and Drug Administration approves breast cancer drugs, Tamoxifen and Herceptin

Anticancer Drugs, Antineoplastic agents, Article

---

More people need cholesterol drugs

Article Abstract:

Almost one out of five adults in the US should be taking medication to lower their cholesterol levels, according to guidelines released on May 15, 2001 by the National Cholesterol Education Program (NCEP). High cholesterol is a major risk of heart disease. While lifestyle changes, such as eating less and more fiber, are very effective in lowering LDL, many people need to take cholesterol-lowering drugs to attain the newly lowered goal. The NCEP report consists of 20 months of study by 27 experts.

Lipotropics & Cholesterol Reducers

---

FDA OKs 'monthly injectable pill' contraceptive

Article Abstract:

Pharmacia Corp has received FDA approval for its injectable contraceptive product called Lunelle, which is described as the US' first monthly injectable contraceptive. The main advantage of Lunelle is that women do not have to remember to take their birth control pill daily. The main difference of Lunelle with Devo-Provera, an injectable contraceptive that can be taken every three months, is that it takes only two to four months for women to return to full fertility with the former.

Government regulation (cont), Pharmacia Corp

Similar abstracts:

• Abstracts: FDA probe into antibiotic deaths called inadequate. Heart drug called a lifesaver
• Abstracts: Japanese resistance to change lessens. Cyberspace cafes catching on abroad
• Abstracts: FCC says consumers can buy cable boxes. Motorola bets on television set-top boxes as next big thing. Bickering delays retail debut of set-top cable boxes
• Abstracts: Firestone rating down, but not out. Tire exec to testify; Ford CEO declines. Tire replacement effort `going to hit a wall soon'
• Abstracts: Safety concerns might keep foreign trucks out. Company convicted in crash of ValuJet. Motorists finding logos a gas

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.